Virginia Economic Review

Drake Goolsby is chief commercialization officer at Luna Labs, a Charlottesville-based company that helps develop advanced technologies in biotech, advanced materials, and engineered systems for government, military, and industrial clients.

Like his fellow Type 1 diabetics, Alec Smith took insulin every day to regulate his blood sugar.

The highly transmissible omicron variant of the novel coronavirus upended perceptions about proper mitigation. People who had been wearing fabric masks began switching over to N95 and KN95 respirators, leading to greater demand for respirators.

Northern Virginia’s advantages in attracting talent are well known, from best-in-class public schools, to vibrant communities, to the attractions and sights of Washington, D.C.

COVID-19 has underscored the value of businesses embracing digital technologies in the healthcare space — from telehealth and remote patient monitoring to artificial intelligence (AI) for predictive analytics and diagnostic insights.

Like many medical device startups, Luminoah began with a bright idea brought about by a personal need. In 2019, founder Neal Piper’s young son, Noah, had a medical issue that necessitated the use of a feeding tube.

Chandra Briggman is president and CEO of Activation Capital, an independent authority that supports life sciences and advanced technology companies and entrepreneurship in the Richmond area.

John Newby is CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in the Commonwealth.

Technological advancements, supply chain disruptions, and safety, environmental, and other sociopolitical factors are changing the way people and products move around the country. Manufacturers are leveraging technology, new business models, and infrastructure improvements to chart a future path.